Ticker Details
Myriad Genetics, Inc. Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.
IPO Date:	October 6, 1995
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$415.18M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.49 | 1.92%
Avg Daily Range (30 D):	$0.13 | 2.69%
Avg Daily Range (90 D):	$0.15 | 2.62%

Institutional Daily Volume
Avg Daily Volume:	.84M
Avg Daily Volume (30 D):	1.39M
Avg Daily Volume (90 D):	.98M

Trade Size
Avg Trade Size (Sh.):	120
Avg Trade Size (Sh.) (30 D):	86
Avg Trade Size (Sh.) (90 D):	75

Institutional Trades
Total Institutional Trades:	11,833
Avg Institutional Trade:	$1.85M
Avg Institutional Trade (30 D):	$2.3M
Avg Institutional Trade (90 D):	$1.64M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.47M
Avg Closing Trade (30 D):	$2.8M
Avg Closing Trade (90 D):	$1.76M
Avg Closing Volume:	114.12K

News

Feb 16, 2026 @ 9:15 PM Myriad Genetics to Release Fourth Quarter and Full... Source: Na

Feb 13, 2026 @ 3:00 PM Decoding Our DNA: The Human Impact Behind SNP Geno... Source: Towards Healthcare

Jan 30, 2026 @ 9:57 AM Esoteric Testing Research Report 2026 - Global $41... Source: Researchandmarkets.Com

Jan 16, 2026 @ 10:58 AM Global Pan-Genomic and Multi-Gene Panel Testing Ma... Source: Analystview Market Insights

Dec 30, 2025 @ 3:00 PM Reproductive Genetics Market Size to Reach USD 16.... Source: Coherent Market Insights

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.95	$-.07	$-3.95
Diluted EPS	$-3.95	$-.07	$-3.95
Revenue	$824.5M	$209.8M	$824.5M
Gross Profit	$576.6M	$146.8M	$576.6M
Net Income / Loss	$-365.9M	$-7.9M	$-365.9M
Operating Income / Loss	$-387.2M	$-5.7M	$-387.2M
Cost of Revenue	$247.9M	$63M	$247.9M
Net Cash Flow	$39.4M	$-3.5M	$39.4M
PE Ratio

Splits
Mar 26, 2009	2:1
Sep 12, 2000	2:1